Cancer Immunotherapeutics Members

Behnam Badie, M.D., is a renowned neurosurgeon and expert in the field of surgical neuro-oncology, nanotechnology and T cell research.

Christine Brown, Ph.D., is deputy director of the T Cell Therapeutics Research Laboratory at Beckman Research Institute of City of Hope.

Michael A. Caligiuri, M.D., is a world-renowned physician, scientist, builder, innovator, leader and visionary. He is dedicated to developing the next generation of leading-edge cancer therapies.

Don J. Diamond, Ph.D., is Professor in the Department of Hematology & Hematopoietic Cell Transplantation.

Mingye Feng, Ph.D., is an associate professor in the Department of Immuno-Oncology

Yuman Fong, M.D., is an internationally recognized expert in cancer of the liver, pancreas, gallbladder and bile ducts. He has led the research effort to employ genetically modified viruses to destroy cancer cells.

Marcin Kortylewski, Ph.D., is a professor in the Department of Immuno-Oncology, focuses on cancer immunotherapy.

Peter P. Lee, M.D., is professor and chair in the department of Immuno-Oncology, Beckman Research Institute of City of Hope in Southern California and beneficiary of The Christopher Family Endowed Innovation Fund for Alzheimer's Disease and Breast Cancer Research in Honor of Vineta Christopher.

Edwin Manuel, Ph.D., is Assistant Professor in the Department of Immuno-Oncology.

Heather McGee, M.D., Ph.D., is an assistant professor in the Department of Radiation Oncology and Department of Immuno-Oncology at City of Hope.

Laleh G. Melstrom, M.D., M.S., specializes in melanoma and pancreatic cancers.

Listed numerous times as one of America’s Castle Connolly Top Doctors®, Joanne Mortimer, M.D., is the Baum Family Professor in Women’s Cancers. She takes a special interest in examining how hormones affect normal and tumor cells.

Javier Gordon Ogembo, Ph.D., is associate professor in the Department of Immuno-Oncology at Beckman Research Institute of City of Hope.

John Shively, Ph.D., is a professor in the Department of Immunology & Theranostics within the Diabetes & Metabolism Research Institute at City of Hope.

Leo David Wang, M.D., Ph.D., is a pediatric hematologist-oncologist and associate professor in the departments of Immuno-Oncology and Pediatrics.

City of Hope's John Williams, Ph.D., is a professor in the Department of Cancer Biology and Molecular Medicine and Director of the X-ray Crystallography Core.

Jeffrey Wong, M.D., is renowned for his efforts in targeted therapy using image-guided/intensity modulated radiotherapy, recently applying this approach to bone marrow transplantation.

Yanghee Woo, M.D., is director of the Gastroenterology Minimally Invasive Therapy Program.

Anna Wu, Ph.D., is chair of the Department of Immunology & Theranostics and co-director of the Center for Theranostic Studies.

Paul Yazaki, Ph.D., is a research professor in the Department of Immunology & Theranostics at the Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope.

Hua Yu, Ph.D., associate chair of the Department of Immuno-Oncology, has made STAT3 the focus of much of her research.

Kirstin Anja Zettlitz, Ph.D., is an assistant professor in the Department of Immunology & Theranostics within the Diabetes & Metabolism Research Institute at City of Hope.

Chunyan Zhang is a staff scientist in the department of immuno-oncology at the Beckman Research Institute of City of Hope.